References
- Abi-Said D, Anaissie E, Uzun O, et al. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997;24:1122–8
- Bernhardt J, Zimmermann K, Schulz K, et al. Oesophageal candidosis in intensive care patients. Mycoses 2000;43:377–9
- Sims CR, Ostrosky-Zeichner L, Rex JH. Invasive candidiasis in immuno compromised hospitalized patients. Arch Med Res 2005;36:660–71
- Gupta AK, Tomas E. New antifungal agents. Dermatol Clin 2003;21:565–76
- Kao AS, Brandt ME, Pruitt WR, et al. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis 1999;29:1164–70
- Zaoutis TE, Argon J, Chu J, et al. The epidemiology and attrib utable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 2005;41:1232–9
- Gudlaugsson O, Gillespie S, Lee K, et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 2003;37:1172–7
- Rentz AM, Halpern MT, Bowden R. The impact of candidemia on length of hospital stay, outcome, and overall cost of illness. Clin Infect Dis 1998;27:781–8
- Morgan J, Meltzer MI, Plikaytis BD, et al. Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol 2005;26:540–7
- HCUP Overview. Healthcare Cost and Utilization Project (HCUP). Rockville, MD: Agency for Healthcare Research and Quality, 2004 Oct. Available at: www.hcup-us.ahrq.gov/overview.jsp [Last accessed 17 July 2007]
- Naito Y, Yoshikawa T, Oyamada H, et al. Esophageal candidiasis. Gastroenterol Jpn 1988;23:363–70